ARTICLE | Distillery Therapeutics
Endocrine/Metabolic
June 20, 2018 7:05 PM UTC
Patient sample and mouse studies suggest inhibiting ANGPTL4 could help treat insulin resistance. In non-diabetic individuals, a loss-of-function mutation in ANGPTL4 was associated with low levels of f...
BCIQ Company Profiles
BCIQ Target Profiles